ADvantage Therapeutics Inc.
PrivateLast Round
Grant
Sep 26, 2025
Total Funding Raised
$23M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ADvantage Therapeutics Inc. is a biotechnology company that develops novel therapies for neurodegenerative conditions, with a primary focus on Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ADvantage Therapeutics Inc. Comparables
Compare ADvantage Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Klothea Bio, Inc. | 87% | |
| Klotho Therapeutics, Inc. | 85% | |
| Klotho Sciences | 84% |
ADvantage Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 26, 2025 | ||||
| Seed | Nov 25, 2024 | ||||
| Early Funding | Jul 12, 2023 | ||||
| Seed | Jun 1, 2022 |
Key People
Founding team and executive leadership
ADvantage Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longevitytech.fund | Seed |
| National Institute on Aging | Grant |
| quadraScope Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 45% MoM.
- Oct 9, 2025
Preparing for Phase 1B trial of next-generation Klotho therapeutics.
ADvantage Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ADvantage Therapeutics Inc.'s valuation, stock price, and market status.
Is ADvantage Therapeutics Inc. a public or private company?
ADvantage Therapeutics Inc. is a private company.
What is the current stock price of ADvantage Therapeutics Inc.?
ADvantage Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is ADvantage Therapeutics Inc. worth (valuation)?
Valuation information for ADvantage Therapeutics Inc. is not publicly available.
Can I buy ADvantage Therapeutics Inc. stock?
ADvantage Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ADvantage Therapeutics Inc.'s last funding round?
ADvantage Therapeutics Inc.'s most recent funding round was Early Funding on July 12, 2023.
Who are the main investors in ADvantage Therapeutics Inc.?
Key investors in ADvantage Therapeutics Inc. include quadraScope Ventures.
Will ADvantage Therapeutics Inc. IPO soon?
No public IPO plans have been announced for ADvantage Therapeutics Inc..
How can I track ADvantage Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ADvantage Therapeutics Inc.'s secondary market activity and sign up for updates.